| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.04 |